⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2321562 | 1.00 | — | — | |
| SCHEMBL890174 | 1.00 | — | — | |
| Bromide SCHEMBL6143076 | 0.98 | — | — | |
| Bromide SCHEMBL6143081 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL6147870 | 0.98 | — | — | |
| SCHEMBL18731092 | 0.93 | — | — | |
| SCHEMBL10367186 | 0.93 | — | — | |
| SCHEMBL17928477 | 0.87 | — | — | |
| SCHEMBL6143108 | 0.79 | NOS2 (0.52) | — | |
| SCHEMBL6143295 | 0.79 | NOS2 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3818059-B1 | INTERMEDIATES IN THE SYNTHESIS OF C3-SUBSTITUTED CEPHALOSPORINS | NORBROOK LAB LTD (GB) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024026481-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| US-11840544-B2 | Intermediates in the synthesis of C3-substituted cephalosporins | NORBROOK LABORATORIES LIMITED (GB) | 2023-12-12 | — | — | US | disclosed |
| US-11840544-B2 | Intermediates in the synthesis of C3-substituted cephalosporins | NORBROOK LABORATORIES LIMITED (GB) | 2023-12-12 | — | — | US | disclosed |
| US-11840544-B2 | Intermediates in the synthesis of C3-substituted cephalosporins | NORBROOK LABORATORIES LIMITED (GB) | 2023-12-12 | — | — | US | disclosed |
| US-RE49686-E1 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
| WO-2023137113-A2 | CHEMICALLY REVERSIBLE 2´-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-07-20 | — | — | WO | disclosed |
| WO-2023083295-A1 | ESTER DERIVATIVES OF N4-HYDROXYCYTIDINE AND USE THEREOF | SUZHOU SPRING-SEA BIO-PHARMACEUTICALS CO., LTD. (CN) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023066292-A1 | TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海济煜医药科技有限公司 | 2023-04-27 | — | — | WO | disclosed |
| US-20230013585-A1 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS | GILEAD SCIENCES, INC. | 2023-01-19 | — | — | US | disclosed |
| US-20070043009-A1 | Quinazoline derivatives as tyrosine kinase inhibitors | ASTRAZENECA AB (SE) | 2007-02-22 | — | — | US | disclosed |
| EP-1339723-B1 | PROCESS AND ESTER DERIVATIVES USEFUL FOR PREPARATION OF CEPHALOSPORINS | PFIZER PROD INC (US) | 2006-03-08 | — | — | EP | disclosed |
| EP-1318148-B1 | Method of preparing optically pure (R)- or (S)- tetrahydrofuranyl ketone | SK CORP (KR) | 2005-01-12 | — | — | EP | disclosed |
| US-6841688-B2 | Method of preparing optically pure (R)- or (S)- tetrahydrofuranyl ketone | SK CORPORATION (KR) | 2005-01-11 | — | — | US | disclosed |
| US-20040267008-A1 | Process and ester derivatives useful for preparation of cephalosporins | PFIZER INC | 2004-12-30 | — | — | US | disclosed |
| EP-1339723-A1 | PROCESS AND ESTER DERIVATIVES USEFUL FOR PREPARATION OF CEPHALOSPORINS | Pfizer Products Inc. (US) | 2003-09-03 | — | — | EP | disclosed |
| US-20030114693-A1 | Method of preparing optically pure (R) - or (S) - tetrahydrofuranyl ketone | SK CORPORATION | 2003-06-19 | — | — | US | disclosed |
| EP-1318148-A1 | Method of preparing optically pure (R)- or (S)- tetrahydrofuranyl ketone | SK Corporation (KR) | 2003-06-11 | — | — | EP | disclosed |
| US-20020099205-A1 | Process and ester derivatives useful for preparation of cephalosporins | PFIZER INC. | 2002-07-25 | — | — | US | disclosed |
| WO-2002046199-A1 | PROCESS AND ESTER DERIVATIVES USEFUL FOR PREPARATION OF CEPHALOSPORINS | PFIZER PRODUCTS INC. (US) | 2002-06-13 | — | — | WO | disclosed |